BRIDGE: a multi-stakeholder workstream focused on assessing new clinical endpoints in ophthalmology clinical trials (Building Research Innovations and Developing Global Endpoints) : comment - Sivaprasad, Sobha; Loewenstein, Anat; Carneiro, Angela; Midena, Edoardo; Bandello, Francesco; Terheyden, Jan H.; Korobelnik, Jean-François; Zarranz-Ventura, Javier; Viola, Francesco; Munk, Marion R.; Eter, Nicole; Lanzetta, Paolo; et al. (Eye, 2025)
Im Titel sind bei "Building Research Innovations and Developing Global Endpoints" jeweils die Anfangsbuchstaben unterstrichen
Mitglieder der The Bridge Study Group: Sobha Sivaprasad, Anat Loewenstein, Angela Carneiro, Edoardo Midena, Francesco Bandello, Jan H. Terheyden, Jean-François Korobelnik, Javier Zarranz-Ventura, Francesco Viola, Marion R. Munk, Nicole Eter, Paolo Lanzetta, Richard Gale, Stela Vujosevic, Tunde Peto, Francesco Faraldi, José Cunha-Vaz, Robert P. Finger, Antonia Joussen, Daniel Pauleikhoff, Florent G. Revel, Nadia Zakaria, Thomas Fussaro, Ine de Goeij, Sharon Bakalash, Andrew Want, Daniel Urban, H. Nida Sen, Alyson Berliner, Carl-Gustav Olsen Glittenberg, Anke Webler-Messenger, Jennifer Lynn Pluim, Michael Tolentino, David Callanan, Caroline Baumal, Reza Safaei, Rafiq Hasan, Muhammad Ali Memon, Michelle Sylvanowicz, Joao Carrasco, Natalia Rodellar Sasot, Thomas F. Miller, Laila Narouz-Ott, Silvia Specker and Fabio Baschiera
Gesehen am 22.09.2025